Cover Image

Withaferin A: A potential anticancer candidate drug and its challenges for the clinical trial

-

Saved in:

Bibliographic Details
Main Authors:	Sangilimuthu Alagar Yadav (Author), Ranjusha V. Ponattil (Author)
Format:	Book
Published:	AOSIS, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating anticancer properties of Withaferin A-a potent phytochemical
by: Maushma Atteeq
Published: (2022)

Withaferin A: a potential therapeutic agent against COVID-19 infection
by: Alex R. Straughn, et al.
Published: (2020)

Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant <i>Withania somnifera</i> (L.) Dunal
by: Suneel Kumar, et al.
Published: (2023)

Inhibition of Monosodium Urate Crystal-Induced Inflammation by Withaferin A
by: Mahaboobkhan Rasool, et al.
Published: (2009)

The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates
by: Rachel J. Church, et al.
Published: (2021)

Discovery of eukaryotic cellular receptor for Withaferin A, a multifaceted drug from Withania somnifera plant
by: Varsha D. Shiragannavar, et al.
Published: (2022)

Tackling Chronic Inflammation with Withanolide Phytochemicals-A Withaferin A Perspective
by: Emilie Logie, et al.
Published: (2020)

Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
by: Xing Z, et al.
Published: (2023)

Imidazole and its derivatives as potential candidates for drug development
by: Amara Mumtaz, et al.
Published: (2016)

Screening and assessment of molecular mechanistic actions of 5-hydroxy-1-methylpiperidin-2-one against free radicals, lung cancer cell line (A549), and binding properties on bovine serum albumin
by: Sangilimuthu Alagar Yadav, et al.
Published: (2021)

Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
by: Alex R. Straughn, et al.
Published: (2019)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
by: Zhaowu Ma, et al.
Published: (2021)

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
by: Shasank Sekhar Swain, et al.
Published: (2023)

Withaferin A inhibits osteosarcoma cells through inactivation of Notch-1 signalling
by: Yang Chen, et al.
Published: (2014)

Withaferin A protects against spinal cord injury by inhibiting apoptosis and inflammation in mice
by: Xianlei Yan, et al.
Published: (2017)

Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid
by: Qinghua Wang, et al.
Published: (2024)

SYNTHESIS AND CHARACTERIZATION OF SILVER NANOPARTICLES CONTAIN CURCUMIN AS AN EARLY CANDIDATE FOR ANTICANCER DRUG
by: Ersalina Nidianti, et al.
Published: (2021)

Age-related hearing loss and its potential drug candidates: a systematic review
by: Shiyu Hu, et al.
Published: (2023)

Candidate drug repurposing for malaria: perspectives for optimising clinical trials
by: J. Luis Espinoza
Published: (2025)

Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases
by: Dilipkumar Pal, et al.
Published: (2022)

Withaferin A ameliorates ovarian cancer-induced renal damage through the regulation of expression of inflammatory cytokines
by: Kusum Kumar, et al.
Published: (2024)

Overexpression of MicroRNA-25 by Withaferin A Induces Cyclooxygenase-2 Expression in Rabbit Articular Chondrocytes
by: Ju-Hee Kim, et al.
Published: (2014)

Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation
by: Huang Shan, et al.
Published: (2009)

Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System
by: Kshitis Chandra Baral, et al.
Published: (2021)

Potential Rx-to-OTC Switch Drug Candidates
by: Victor Phan, et al.
Published: (2016)

Formononetin: A Review of Its Anticancer Potentials and Mechanisms
by: Kai-Ching Tay, et al.
Published: (2019)

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
by: Swarna Bale, et al.
Published: (2018)

Withaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress
by: Tsu-Ming Chien, et al.
Published: (2021)

Low Dose Combined Treatment with Ultraviolet-C and Withaferin a Enhances Selective Killing of Oral Cancer Cells
by: Sheng-Yao Peng, et al.
Published: (2020)

Fexinidazole: a potential new drug candidate for Chagas disease.
by: Maria Terezinha Bahia, et al.
Published: (2012)

Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
by: Elena Marchesi, et al.
Published: (2023)

Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment
by: Apurva Sood, et al.
Published: (2024)

The Anticancer Potential of Maslinic Acid and Its Derivatives: A Review
by: Yu L, et al.
Published: (2021)

Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
by: Cangcang Xu, et al.
Published: (2020)

Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential
by: Shivani Khattar, et al.
Published: (2022)

Ebola vaccines in clinical trial: The promising candidates
by: Yuxiao Wang, et al.
Published: (2017)

Possible potential of Astrodaucus genus in development of anticancer drugs
by: Narges Ghorbani Hesari, et al.
Published: (2021)

Design and computational study of the thiourea-cobalt(III) complex as an anticancer candidate
by: Ruswanto Ruswanto, et al.
Published: (2023)

Synthesis and computational study of metal complex of α-mangostin as an anticancer candidate
by: Richa Mardianingrum, et al.
Published: (2024)

A systematic review: Molecular docking simulation of small molecules as anticancer non-small cell lung carcinoma drug candidates
by: Syahrul Hidayat, et al.
Published: (2022)